Sciences of Phytochemistry (SciPhy) is a peer-reviewed journal published by ETFLIN. SciPhy aims to offer a widely visible and highly indexed platform for scholars and intellectuals (especially the youth) to share their scientific opinions, valuable insights and scholarly works.

Start year: 14 June 2022

Language: English

Journal DOI:

Publication fee: Zero, No article processing charge

Publishing model: Gold Open Access

Free access: Immediate

Issues per year: 2 issues (biannual)

Peer review: Double blind

Review speed: 7-30 days

Acceptance to publication: 0-2 days

Reviewers per article: 2


SciPhy accepts original article, review, mini-review, technical note, case report, clinical trial, opinion/perspective, and conference proceeding that falls within the scope of the journal.

  1. Pharmacognosy and Phytochemistry

    Pharmacognostical characterization of medicinal plants, phytochemical screening of plant extracts (including fractions and purified fractions), isolation of phytocompounds (including its purification and characterization).

  2. Pharmacology and Toxicology

    Evaluation of the pharmacological activity and toxicity of medicinal plants (including phytocompounds or herbal formulations).

  3. Ethnobotany and Ethnopharmacology

    Field survey and documentation of traditionally important medicinal plants used by ethnic/tribal groups.

  4. Nutraceuticals

    Foods or vegetables having medicinal value. This will also include medicinal plants that are regularly consumed as vegetables.

  5. Pharmaceutics

    Development, characterization, and evaluation of herbal formulations wherein medicinal plant(s) or phytocompound(s) acts as the main active ingredient. Isolation and characterization of polymers from plants having pharmaceutical importance. Application of nanotechnology for herbal formulation development, increasing bioavailability of phytocompounds and site-specific delivery of phytocompounds.

  6. In-silico

    Application of computer-aided drug design, bioinformatics, machine learning, artificial intelligence, network pharmacology, and systems biology to evaluate the in-silico pharmacological activity (or ADMET profile) of phytocompounds (including lead identification from a phytocompound library, or identification of potential drug targets for phytocompounds). Articles reporting in-silico design and screening of synthetic analogs/semi-synthetic derivatives of phytocompounds shall be considered only if the newly designed compounds outperforms the original phytocompounds in all areas.

  7. Clinical

    Clinical studies evaluating the safety and efficacy of medicinal plants, phytocompounds and herbal formulations. Pharmacovigilance of medicinal plants shall cover drug-phytocompound interactions and adverse drug reactions due to consumption of medicinal plant products.

  8. Method development

    Development and validation of bioassay, analytical, qualitative or quantitative methods with significant utility in the field of pharmacognosy and phytochemistry.

  9. Miscellaneous

    Medicinal plant biotechnology, medicinal plant chemistry, cultivation of medicinal plants and commercialization of medicinal plant products.